Mycosamine orientation of amphotericin B controlling interaction with ergosterol: Sterol-dependent activity of conformation-restricted derivatives with an amino-carbonyl bridge

被引:77
作者
Matsumori, N [1 ]
Sawada, Y [1 ]
Murata, M [1 ]
机构
[1] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan
关键词
D O I
10.1021/ja051597r
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Amphotericin B (AmB 1) is known to assemble together and form an ion channel across biomembranes. The antibiotic consists of mycosamine and macrolactone moieties, whose relative geometry is speculated to be determinant for the drug's channel activity and sterol selectivity. To better understand the relationship between the amino-sugar orientation and drug's activity, we prepared conformation-restricted derivatives 2-4, in which the amino and carboxyl groups were bridged together with various lengths of alkyl chains. K+ influx assays across the lipid-bilayer membrane revealed that ergosterol selectivity was markedly different among derivatives; short-bridged derivative 2 almost lost the selectivity, while 3 showed higher ergosterol preference than AmB itself. Monte Carlo conformational analysis of 2-4 based on NOE-derived distances indicated that the amino-sugar moiety of 2 comes close to C41 because of the short bridge, whereas those of 3 and 4 are pointing outward. The mutual orientation of the amino-sugar moiety and macrolide ring is so rigid in derivatives 2 and 3 that these conformations should be unchanged upon complex formation in lipid membranes. These results strongly suggest that the large difference in sterol preference between derivatives 2 and 3 is ascribed to the different orientation of amino-sugar moieties. These findings allowed us to propose a simple model accounting for AmB-sterol interactions, in which hydrogen bonding between 2'-OH of AmB and 3 beta-OH of ergosterol plays an important role.
引用
收藏
页码:10667 / 10675
页数:9
相关论文
共 54 条
[1]  
Ablordeppey SY, 1999, CURR MED CHEM, V6, P1151
[2]   STRUCTURE AND FUNCTION OF AMPHOTERICIN B-CHOLESTEROL PORES IN LIPID BILAYER MEMBRANES [J].
ANDREOLI, TE .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 235 (MAY10) :448-468
[3]   Distribution of electrostatic potential around amphotericin B and its membrane targets [J].
Baginski, M ;
Borowski, E .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 1997, 389 (1-2) :139-146
[4]   Comparative molecular dynamics simulations of amphotericin B-cholesterol/ergosterol membrane channels [J].
Baginski, M ;
Resat, H ;
Borowski, E .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1567 (1-2) :63-78
[5]  
BAGINSKI M, 1994, J MOL STRUC-THEOCHEM, V117, P285, DOI 10.1016/S0166-1280(09)80066-3
[6]   Conformational analysis of Amphotericin B [J].
Baginski, M ;
Gariboldi, P ;
Bruni, P ;
Borowski, E .
BIOPHYSICAL CHEMISTRY, 1997, 65 (2-3) :91-100
[7]   Molecular properties of amphotericin B membrane channel: A molecular dynamics simulation [J].
Baginski, M ;
Resat, H ;
McCammon, JA .
MOLECULAR PHARMACOLOGY, 1997, 52 (04) :560-570
[8]   Molecular modelling of amphotericin B-ergosterol primary complex in water [J].
Baran, M ;
Mazerski, J .
BIOPHYSICAL CHEMISTRY, 2002, 95 (02) :125-133
[9]   The interactions of amphotericin B with various sterols in relation to its possible use in anticancer therapy [J].
Charbonneau, C ;
Fournier, I ;
Dufresne, S ;
Barwicz, J ;
Tancrède, P .
BIOPHYSICAL CHEMISTRY, 2001, 91 (02) :125-133
[10]   QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS IN AMPHOTERICIN-B DERIVATIVES [J].
CHERON, M ;
CYBULSKA, B ;
MAZERSKI, J ;
GRZYBOWSKA, J ;
CZERWINSKI, A ;
BOROWSKI, E .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :827-836